Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Prudential Jennison Health Sciences Fund Class B (PHLBX)

26.09
Net Asset Value
-1.66%
1 Day
-24.81%
Year-to-Date
Overall Morningstar Rating
Health
Style or Category
No Load
Sales Expenses
1.83%
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation. The fund seeks investments whose price will increase over time. The fund normally invests at least 80% of its investable assets in equity and equity-related securities of companies within the health sciences sector, such as pharmaceutical companies, biotechnology companies, medical device manufacturers, healthcare service providers and health maintenance organizations (HMOs) and other companies that derive at least 50% of their assets, revenues or profits from operations in the healthcare sector. The fund is non-diversified.

Performance

1 month-14.29% 3 years+14.25%
3 months-23.38% 5 years+17.22%
1 year-24.44% Since inception+14.41%
Data through --

Peer Comparisonvs. Health

 PHLBXCategory
Performance 5-yr return+17.22%+21.20%
Expense ratio1.83%1.36%
Risk 5 year sharpe ratio0.991.12
Net assets$2.6B$3.4B
Average market cap$16.4B$36.5B
Average P/E26.822.4
Portfolio turnover52%52%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyPrudential Investments
Fund manager & tenureDavid Chan / 16 Years
Minimal initial investment$2,500.00
Minimum IRA investment$1,000.00

Holdings

U.S. stock89.19%
International stock8.86%
Cash1.49%
Fixed income0.45%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 97.95%
Consumer service 1.34%
Business service 0.00%
Consumer goods 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
BMRN Biomarin Pharmaceutical Inc5.51%
CELG Celgene4.77%
BMY Bristol-Myers Squibb3.77%
SHPG Shire3.58%
ALXN Alexion Pharmaceuticals Inc3.30%
AGN Allergan3.16%
INCY Incyte Corp2.92%
CI Cigna Corp2.87%
PFE Pfizer2.83%
MDT Medtronic PLC2.78%

Partner Offers